BILL · 2017–18 SESSION

SB 6506: Diversity in clinical trials

Concerning improving diversity in clinical trials.

Summary

Requires the Washington State Institutional Review Board (WSIRB) to establish a diversity in clinical trials program.
Requires state entities that conduct clinical trials for drugs or medical devices to adopt a policy for identifying and recruiting participants from underrepresented demographic groups.

From the Senate Bill Report (Orig.) (SB 6506), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to improving diversity in clinical trials;

No recorded floor votes. This measure never reached a floor vote.

Bill numbers restart every two years, so the same number is a different bill in each session.

SB 6506 (2019–20) Liquor license/postsecondary · Did not pass · died in committee
SB 6506 (2015–16) Rail transport. task force · Did not pass · died in committee
SB 6506 (2013–14) Employees of state hospitals · Did not pass · died in committee
SB 6506 (2011–12) Franchisees/workers' comp · Did not pass · died in committee
SB 6506 (2009–10) I-90 floating bridge tolls · Did not pass · died in committee
SB 6506 (2007–08) Medical quality assurance · Did not pass · died in committee
SB 6506 (2005–06) Building permit moratoriums · Did not pass · died in committee
SB 6506 (2003–04) Real estate appraisers · Did not pass · stalled on the Senate floor